Imbio RV/LV Software vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Imbio RV/LV Software

by Imbio

AI-ECG Platform

by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

Tool A specializes in analyzing CTPA scans to measure right and left ventricular diameters for risk stratification in pulmonary conditions. In contrast, Tool B focuses on interpreting 12-lead resting ECGs to diagnose various cardiovascular diseases based on electrical activity. While both fall under cardiology AI, they process different data types and address distinct diagnostic needs, making them complementary rather than directly competitive.

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your clinical workflow frequently involves CTPA scans and you require automated, rapid, and precise measurement of right and left ventricular diameters. This tool is ideal for aiding in the risk stratification of patients with suspected pulmonary embolism or other pulmonary conditions by providing an accurate RV/LV ratio directly integrated into your PACS.

View Imbio RV/LV Software →

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your practice demands a highly accurate and rapid AI-powered system for interpreting 12-lead resting ECGs across a wide range of cardiovascular conditions. This platform is best suited for scenarios where physicians need immediate assistance in diagnosing arrhythmias, ventricular hypertrophy, myocardial ischemia, or myocardial infarction, compatible with most existing ECG machines.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Imbio RV/LV Software	AI-ECG Platform
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]	Workstation (with GPU), web-based portal, Windows-based diagnostic client
FDA Status	Yes AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Imbio RV/LV Software	AI-ECG Platform
Name	Imbio RV/LV Software	AI-ECG Platform
Company	Imbio	Shenzhen Carewell Electronics Co., Ltd.
Primary Data Analyzed	CTPA scans	12-lead resting ECGs
Core Analytical Function	Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio	AI automatic analysis and diagnosis system for ECG, assisting physicians in interpreting 12-lead resting ECGs
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and AI-ECG Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and patient populations each tool is designed for?

Imbio RV/LV Software is designed to automatically measure right and left ventricular diameters from CTPA scans, providing an RV/LV ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. The AI-ECG Platform is an AI-powered system for automatic analysis and diagnosis of 12-lead resting ECGs, assisting physicians in interpreting various cardiovascular diseases such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.

What types of medical data do these tools analyze, and what are their compatibility requirements?

Imbio RV/LV Software analyzes DICOM compliant CTPA scans, utilizing non-gated, contrast-enhanced 3D volumetric acquisitions. The AI-ECG Platform supports various ECG data formats, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG, and is designed to be hardware independent, compatible with most ECG machines.

Beyond basic analysis, what specific diagnostic insights or reports do these tools generate for physicians?

Imbio RV/LV Software automatically calculates and reports the RV/LV ratio, provides annotated images showing ventricular measurements, and generates summary PDF reports. The AI-ECG Platform provides AI-powered automatic analysis and diagnosis for arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, along with features for professional ECG review, waveform measurement, and report generation.

What performance metrics are available regarding the accuracy or speed of analysis for each tool?

The AI-ECG Platform claims over 95% accuracy in diagnosing major cardiovascular diseases and offers rapid diagnosis in approximately 3 seconds. Imbio RV/LV Software focuses on automated measurement and reporting of RV/LV ratios from CTPA scans, with results available within minutes of analysis.

How are these tools typically priced, and what factors influence the cost?

Imbio RV/LV Software is subscription-based, with pricing determined by the number of analyses and installations. For the AI-ECG Platform, pricing information requires direct contact with the company.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform